Bio-Thera Solutions Has China’s First Adalimumab Biosimilar

Qletli Is Only The Second Biosimilar Approved In China

 
• By David Wallace
Thumbs_Up_China
China’s NMPA has approved Bio-Thera Solutions’ Adalimumab • Source: Shutterstock

More from Biosimilars

More from Products